Dataset Open Access

Optimising C2C12 muscle myoblast transfection with polyethylenimine (PEI) or Lipofectamine-2000

Brown, Elizabeth; Bullock, Alex

Optimisation of DNA transfection of the C2C12 muscle myoblast cell line, comparing use of polyethylenimine (PEI) and Lipofectamine-2000 with varying treatment conditions. 

Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files (978.6 kB)
Name Size
Optimising_C2C12_transfection_methods_20180129.pdf
md5:57550e38e150abeaca200002f539559a
978.6 kB Download
744
484
views
downloads
All versions This version
Views 744745
Downloads 484484
Data volume 473.6 MB473.6 MB
Unique views 696697
Unique downloads 447447

Share

Cite as